Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Cosmos Health Inc.

NASDAQ: COSM · Trade & Services · 4 alerts · CIK 1474167

Share price
$2.49Close, Nov 16
Market cap
$251M
Shares outstanding
100.63MLatest SEC cover page
Sector
Trade & Services
Industry
Wholesale-Drugs, Proprietaries & Druggists' SundriesSIC 5122

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Cosmos Health Inc. filings on SEC EDGAR ↗

5:28 PM ET 8-K/A
Reverse Stock Split

Cosmos Health Reverse Stock Split

Cosmos Health Inc. has announced a 1-for-20 reverse stock split of its outstanding common stock, effective November 13, 2026. The company filed a Certificate of Amendment to its Articles of Incorporation to effect the split, while maintaining its authorized common stock at 1.5 billion shares. The move follows discretionary authority granted by shareholders at the 2025 annual meeting.

8:48 AM ET 8-K
Reverse Stock Split

Cosmos Health Reverse Stock Split

Cosmos Health Inc. has filed a Certificate of Amendment to its Articles of Incorporation to effect a 1-for-20 reverse stock split of its outstanding common stock. The split is scheduled to become effective on November 12, 2026, while the company's authorized share count will remain unchanged at 1.5 billion shares.

11:50 AM ET 8-K
Business Update

Cosmos Health Business Update

Cosmos Health provided a business update for its U.S. operations, projecting Q4 2026 U.S. revenue of approximately $15 million and gross profit of $10.5 million. The company reported significant momentum in its direct-to-consumer subscription model, with active U.S. subscriptions increasing 42% to 8,940 in just five days.

5:00 PM ET 8-K
Business Update

Cosmos Health Business Update

Cosmos Health reported record preliminary nine-month revenue of $54.3 million, a 19% increase year-over-year, and record Q3 revenue of $17.4 million. The growth was driven by record production at Cana Laboratories and expanded distribution at CosmoFarm. The company reaffirmed its full-year 2026 revenue guidance of over $90 million.

Term
9 months

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.